Geode Capital Management, LLC Cytosorbents Corp Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 467,058 shares of CTSO stock, worth $382,987. This represents 0.0% of its overall portfolio holdings.
Number of Shares
467,058
Previous 434,643
7.46%
Holding current value
$382,987
Previous $304,000
130.26%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding CTSO
# of Institutions
57Shares Held
16.7MCall Options Held
15.4KPut Options Held
0-
Avenir Corp Washington, DC2.98MShares$2.44 Million0.45% of portfolio
-
Skylands Capital, LLC2.76MShares$2.26 Million0.6% of portfolio
-
Granahan Investment Management, LLC Waltham, MA2.09MShares$1.72 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.6 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.78MShares$1.46 Million0.0% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $35.7M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...